Active substance
Terlipressin diacetate pentahydrate
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GLYPRESSIN 0.1 mg/ml solution for injection | 0.1 mg/ml | Solution for injection · Intravenous use | 5 Ampoule | SAR 625.85 | NCE · Prescription | FERRING | Valid |
| GLYPRESSIN 1MG POWDER FOR I.V. Injection* | 1 mg | Solution for injection · Intravenous use | 5 Vial | SAR 737.55 | NCE · Prescription | FERRING | Valid |
| Terlipressin acetate EVER Pharma | 0.2 mg/ml | Solution for injection · Intravenous use | 5 Vial | SAR 516.30 | Generic · Prescription | EVER Valinject GmbH | Valid |
Indications — CHI Daman Drug Formulary
LIVER CIRRHOSIS
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.